Media & Advertising
Genentech Announces Positive Results From Phase III Study Of Avastin
Have an interest in this Story?
Sign Up for Real-Time email updates
June 02, 2013
Genentech, a unit of the Roche Group (RHHBY.PK) announced the results of study which showed the addition of Avastin to chemotherapy extended the lives of women with advanced cervical cancer, compared to chemotherapy alone.The study met its primary endpoint of improving overall survival with a statis...
Read Full Article
Leave a Comment:
You must be logged in to leave a comment
Most Read Biotech Articles
ESTEVE and UAB advance in their program to develop a cure for Sanfilippo A Syndrome
Rentrak And i360 Partner To Provide Insights For Republican And Conservative Organizations
- KPHO Phoenix
Caisson Biotech Expands HEPtune™ Drug Delivery Deal with Novo Nordisk
- WHBF TV
Zach Galifianakis to Obama: 'What's it like to be the last black president?'
- San Jose Mercury News
AutoCanada Inc. Announces Stock and Cash Deal for Investment in a Group of Two General
- Wards Auto.com
Sir. Paul Anyanwu, CRS,SFR
Real Estate Industry
Genilde Guerra Miami
Attorney at Law - Kravitz & Guerra, PA
View more profiles
Access dozens of premium and subscriptions sites
Build a News Circle
Get News Briefings
Congoo News Home
Get the Netpass
Copyright ©2014 Congoo.com. All Rights Reserved.